BACKGROUND: Cirrhotic patients admitted to the intensive care unit (ICU) usually have multi-organ failure. Multiple organ failure entails a very poor outcome in all intensive care patients. Cirrhotic patients show high morbidity and mortality rates compared with other critically ill patients. Severity scores have been developed for cirrhotic patients admitted to ICU. The main aim of this study was to determine whether lactate level gives any predictive value for mortality in cirrhotic elderly patients admitted to the ICU. METHODS: In all the patients enrolled, a diagnosis of cirrhosis was confirmed either histologically or by resorting to clinical, laboratory, and ultrasonographic findings. During this period, patients with cirrhosis were admitted to the ICU with varying indications. Child-Turcotte-Pugh (CTP), Model for End-stage Liver Disease (MELD), Acute Physiology and Chronic Health Evaluation (APACHE II) and Sequential Organ Failure Assessment (SOFA) scores and lactate were compared between deceased and discharged patients. RESULTS: A total of 90 consenting patients were enrolled in this study. The mean age of all the patients was 69 ± 5.919. We detected etiological factors for cirrhosis as HBV, HCV, alcohol, and cryptogenic cirrhosis. Hepatorenal syndrome and spontaneous bacterial peritonitis were significantly higher in patients who died than in those who were discharged from the ICU (p values were 0.01 and 0.028, respectively). Lactate level, CTP, APACHE II, MELD and SOFA scores were significantly higher in patients who died than in those who were discharged from the ICU (p values were 0.002, < 0.001, < 0.001, and < 0.001, respectively). CONCLUSIONS: Many factors may be useful as a predictor of mortality in ICU in elderly patients with cirrhosis. In terms of prognostic value, the lactate level and APACHE II score are the two best predictive factors in cirrhotic elderly patients admitted to the ICU.
BACKGROUND: Cirrhotic patients admitted to the intensive care unit (ICU) usually have multi-organ failure. Multiple organ failure entails a very poor outcome in all intensive care patients. Cirrhotic patients show high morbidity and mortality rates compared with other critically ill patients. Severity scores have been developed for cirrhotic patients admitted to ICU. The main aim of this study was to determine whether lactate level gives any predictive value for mortality in cirrhotic elderly patients admitted to the ICU. METHODS: In all the patients enrolled, a diagnosis of cirrhosis was confirmed either histologically or by resorting to clinical, laboratory, and ultrasonographic findings. During this period, patients with cirrhosis were admitted to the ICU with varying indications. Child-Turcotte-Pugh (CTP), Model for End-stage Liver Disease (MELD), Acute Physiology and Chronic Health Evaluation (APACHE II) and Sequential Organ Failure Assessment (SOFA) scores and lactate were compared between deceased and discharged patients. RESULTS: A total of 90 consenting patients were enrolled in this study. The mean age of all the patients was 69 ± 5.919. We detected etiological factors for cirrhosis as HBV, HCV, alcohol, and cryptogenic cirrhosis. Hepatorenal syndrome and spontaneous bacterial peritonitis were significantly higher in patients who died than in those who were discharged from the ICU (p values were 0.01 and 0.028, respectively). Lactate level, CTP, APACHE II, MELD and SOFA scores were significantly higher in patients who died than in those who were discharged from the ICU (p values were 0.002, < 0.001, < 0.001, and < 0.001, respectively). CONCLUSIONS: Many factors may be useful as a predictor of mortality in ICU in elderly patients with cirrhosis. In terms of prognostic value, the lactate level and APACHE II score are the two best predictive factors in cirrhotic elderly patients admitted to the ICU.
Authors: J A Noval-Padillo; C Serra-Gomez; L Gomez-Sosa; R Hinojosa-Perez; M J Huici-Moreno; A Adsuar; A Herruzo-Avilés; J L Lopez-Romero; A León-Justel; J M Guerrero-Montavez Journal: Transplant Proc Date: 2011 Jul-Aug Impact factor: 1.066
Authors: Evangelos Cholongitas; Alex Betrosian; Marco Senzolo; Steve Shaw; David Patch; Pinelopi Manousou; James O'Beirne; Andrew K Burroughs Journal: J Gastroenterol Hepatol Date: 2007-12-13 Impact factor: 4.029
Authors: E Cholongitas; M Senzolo; D Patch; K Kwong; V Nikolopoulou; G Leandro; S Shaw; A K Burroughs Journal: Aliment Pharmacol Ther Date: 2006-04-01 Impact factor: 8.171
Authors: P S Kamath; R H Wiesner; M Malinchoc; W Kremers; T M Therneau; C L Kosberg; G D'Amico; E R Dickson; W R Kim Journal: Hepatology Date: 2001-02 Impact factor: 17.425
Authors: Peter Ferenci; Alan Lockwood; Kevin Mullen; Ralph Tarter; Karin Weissenborn; Andres T Blei Journal: Hepatology Date: 2002-03 Impact factor: 17.425
Authors: Nathan I Shapiro; Stephen Trzeciak; Judd E Hollander; Robert Birkhahn; Ronny Otero; Tiffany M Osborn; Eugene Moretti; H Bryant Nguyen; Kyle J Gunnerson; David Milzman; David F Gaieski; Munish Goyal; Charles B Cairns; Long Ngo; Emanuel P Rivers Journal: Crit Care Med Date: 2009-01 Impact factor: 7.598
Authors: Joseph Campbell; Joanne McPeake; Martin Shaw; Alex Puxty; Ewan Forrest; Charlotte Soulsby; Philp Emerson; Sam J Thomson; Tony M Rahman; Tara Quasim; John Kinsella Journal: Crit Care Date: 2015-10-13 Impact factor: 9.097
Authors: Chun Chieh Chu; Chih Min Su; Fu Cheng Chen; Chi Yung Cheng; Hsien Hung Cheng; Chia Te Kung Journal: Medicine (Baltimore) Date: 2021-02-19 Impact factor: 1.817